ADA. A. Derevoedov

A. A. Derevoedov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


A. A. Derevoedov has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Analysis of the effectiveness of countering doping in sports in the framework of medical and biological support for athletes of national teams

    by A. A. Derevoedov, A. V. Zholinsky, V. S. Feshchenko, I. T. Vykhodets, A. A. Pavlova

    Objective: analysis of the effectiveness of combating doping in sports in the process of medical and biological support of athletes forming the national teams of the Russian Federation, and determining its ways.Materials and methods: based on the reports of anti-doping organizations for 2017–2022, sociological studies of the prevalence of doping in sports and therapeutic use structures, a retrospective analysis of the dynamics of the main indicators reflecting the directions of various doping encounters was carried out.Results: a significant discrepancy was revealed between the assessment of the prevalence of anti-doping rule violations based on the results of sociological surveys and the results of laboratory anti-doping studies.A significant positive dynamic of approval of therapeutic use exemptions, which allowed doubling the share of positive decisions of anti-doping organizations is shown.The main directions of improving anti-doping work in the process of carrying out medical and biological support measures are determined.

  • Open Access

    Analysis of doctors’ appeals on the issues of countering doping in sports

    by A. A. Derevoedov, A. V. Zholinsky, V. S. Feshchenko, I. E. Vysotskiy, I. T. Vykhodets, A. A. Pavlova

    Objective: the main topics of the doctors’ questions were the preparation of medical documents for a TUE application, the determination of the anti­doping status of various substances and methods, as well as the use of dietary supplements in sports.Materials and methods: an analysis was carried out of more than 400 appeals of doctors providing medical assistance to athletes of various levels on the issues of countering doping in sports. The aim of the work was to identify ways to improve educational and informational activities aimed at improving the quality of medical documents for TUE applications.Results: the need for continuous work to improve the level of doctors’ knowledge in countering doping in sports was confirmed, including clarification of the procedure for using documents from anti­doping organizations, the need to use TUE guidelines for physicians and the specifics of prescribing substances prohibited only during the competitive period.


  • Open Access

    β2-agonists in sports: prevalence and impact on athletic performance

    by A. A. Derevoedov, A. V. Zholinsky, V. S. Feshchenko, I. T. Vykhodets, A. A. Pavlova

    Respiratory disorders caused by exercise are expressed in the development of exercise-induced bronchoconstriction (EIB) and exercise-induced asthma (EIA), which are observed in athletes, especially in cyclic sports, much more often than in the population. Ventilation impairments are exacerbated by inhaled allergens, industrial pollutants and adverse environmental conditions, which increase the risk of EIB and asthma symptoms in athletes. The use of β2-agonists can prevent or eliminate ventilation disorders, however, it requires taking into account current anti-doping rules, which allow the use of certain substances in sports without a request for therapeutic use. The studies of the influence of β2-agonists on functional indicators of athletes and sports performance do not allow to make an unambiguous conclusion about its results. Medications with β2-agonists, approved for use in sports in the form of inhalation, do not have a significant effect on the performance of athletes at major sports competitions. At the same time, the systemic use of these substances and the use of any form of terbutaline caused a positive dynamics in functional indicators, which could lead to an illegal increase in the effectiveness of sports performance. Most of the conclusions about the effect of β2-agonists on outcome are based on a small number of studies, their heterogeneity, and an insignificant number of observations. It is necessary to continue studying the effects of β2-agonists in the course of randomized clinical trials in order to individualize therapy and prevent bronchial obstruction in athletes